Evangelos Terpos to Combined Modality Therapy
This is a "connection" page, showing publications Evangelos Terpos has written about Combined Modality Therapy.
Connection Strength
0.188
-
Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice. Eur J Haematol. 2018 Oct; 101(4):556-565.
Score: 0.095
-
Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival. Ann Hematol. 2018 Sep; 97(9):1671-1682.
Score: 0.093